Member Info for Aldebaran

Any news from this point will struggle to see HEMO get past recent high thats the problem. Vlad should of had a plan to sustain value with everything he had coming up but he didnt and hear we are.

Own goal and I dread to think what happens when the cash runs out if no proper deal as landed

Has it bin 28 days yet CN?

3 patience safety data.

Supposedly with clean safety profile

All infused with exact same dose

All have exact same condition

Over a month to review and give green light to progress....

Hmmmmmmmmm

Not sitting right with me that. Especially when we had a update one month saying patience alive then next month not even mentioned. Of course you all say its because MDA are holding that info from Vlad but they cant be otherwise he wouldn't have announced their breathing status the month prior.

Somethings up. Hope im wrong but the long silence combined with now 60% reduction in value over same period cant be taken any way other than negative. Cautious at best.

Other companies have 4 years worth of data with a multitude of different warheads, different patients, different doses, different cancers and it is supposedly more high risk than here...

Hmmmmmmmmmm

One company valuation is re-rating upwards at pace, one doesn't even know what its doing.

Hmmmmmmm

Notposting give the guy a bit of slack. He's held for years, suffered God knows what PTSD and sold a few into strength. Can't fault him. He continues to be positive about the company no matter what and sold for personal reasons I gather. I dont believe hes ramping on purpose and selling.

I just think and I mean this in the nicest possible way that he is biased to his core, in love and probably still over exposed and all in on one stock. I actually pitty him a bit.

If the science continues to impress and I hope it does he'll make a fortune and good for him I say. Just lay of him a bit will you. You post some good stuff but seem to have it in for him specifically

JHFH you explicitly said all the remaining warrants are in sticky hands. You are consistently wrong here. I think not deliberately I just think you are biased to your core over exposed and totally hopelessly in love with hemo.

Fine. Its a bit weird but whatever you seem a nice guy tbh so I wish you well.

When referring to avacta which I will continue to do because you lot keep bringing it up so dont have the cheek to tell me not to. So when referring to avacta dont get involved. Its fine to say you are comfortable with hemo you understand hemo and your happy with risk reward of hemo and the communications etc and you dont have time and dont want to research other companies. Thats silly but I get it. Fine.

Just dont make half a s s ed statements about hemo being a better risk reward etc when you haven't done the proper research to find out. Even Saint has had to correct you today. You make yourself look daft. Same as Haywain.

Unless you've done research in avavta properly more than just scratched the surface then sit the thread out boys. Its not for you.

Let's talk about hemo then... any new news? Are the patience still alive? When will we get an update about dose increasing and pediatrics and Estonia? When will vlad give some kind of investor webinar with A Q&A slot? Any chance we can have some information about the DC and NYC conferences? Remember those, the big ones you all said would be transformational for hemo... ?

Up on rising volume

Down on falling volume

Higher highs

Lower lows

Correct order of moving averages

Momentum rising

Plenty of news incoming all signposted by the company

Just placed 16m at reasonable 10% discount with zero warrants

CLN payments deferred until 2027 I.e. AFTER clinical data release

Has their ever been a better risk reward opportunity than right now? I doubt it.

Looks great for a continued run

If only HEMO would give us something to talk about. Chance would be a fine thing.

I despair. But hey, at least traders aren't making money right guys 🙄🔫

Cya for now 👋

Faridoxorubicin you mean, right?

What about exetecan, you know, the most potent topoisomerase inhibitor on Earth, you interested in that?

What about a bi specific peptide drug conjugate carrying exetecan and a PARPi ? No... no Haywain. Your not researched in the slightest. You've scratched the surface.

Same as people that come here and say blah only 3 patients treated. Don't pretend you understand avacta

JHFH you say math ain't mathing. Fine. Care to prove it?

Ive already laid out here detailed DCF calculations and risk reward plus upside potential. Done same for avacta which all available in my post history.

Let's see your numbers then and you can prove mathematically why hemo has more upside potential than avacta.

Spoiler alert, you can't. Ive run the numbers and I know.

Drutor £400bn TAM is the direct answer to your question btw. Avacta mcap just 300m. You run the numbers and tell me which has the greater upside

JHFH. The CLN has been put to bed until 2027. Again, you only done partial research.

Ask yourself this. Avacta sold its diagnostics division. It now has zero revenue. Why on Earth would they CLN provider agree to postpone all payments and take on that risk? What is in it for them? All they have seen is Avacta's protected data and they've gone. Yep. No problem avacta.

A far cry from ancient chemotherapy. They are revolutionising oncology on a scale hemo can only dream of. Hyperbole? Go actually find out yourself rather than doing partial.or no research. Until you've research both companies i dont take your opinion whatsoever.

Im right..I know i am. Because ive research both hemo and avacta. You haven't

Drutor, the upside here is huge no doubt but it could and should be a lot more rewarding for shareholders if the company was managed better.

What people like JHFH et al like to talk about is this being best company since sliced bread without researching any other company. The market cap of avacta is 6x higher but the TAM is orders of magnitude higher than HEMO. There technology is applicable to 90% of cancers. 90%. And it has non oncology uses such as in fibrosis of the liver etc..

Do you have any idea how big that market is?

Hemo has FLT3+ rr AML market.

So as I keep trying to educate, the opportunity here and at avacta are not even on the same scale. Avacta is orders of magnitude bigger.

Is that orders orders or non contractual orders or what?

Either way whatever is announced mid 2026 needs to be seen in the accounts to be believed so 2027 earliest.

For those who took my tip and bought pullback in avacta in low 6's well done 👏

Drutor, don't be to disheartened. Actually the science here is promising. But as I keep saying it takes more than that and everything else about HEMO is simply not up to scratch. Serious advise go look at how avacta is run and managed and its night and day chalk and cheese to here.

Clear road map clear timelines which management can be held to account against.

Commercial strategy in place delivering scientifically, no desperation raises with warrants. HnWI and instituons taking place in placing just last week etc..

Its go time for them.

Here - no clue which is what is killing sentiment and warrant holders are forward selling again. Everyone making money and realising gains apart from the sit and do nothing long term holders. Its not right

10x that, apparently its good that price is falling and the company are not releasing any news because in these lots logic it means traders aren't making any money pmsl

Unless their short of course and using price action to trade hmmmmmm

That alone speaks volumes.

I know market wants third party validation to be absolutely sure it isnt ribena but I just cant see the company presenting at major oncology conferences and working with people of the quality of Dr Tap being liars. Therefore I and we are ahead of the game.

Others want validation, fine.

For what it, is worth. We might never get validation, a sale may well or take over may well just come out of the blue for everyone. Only those who done the research and holding will benefit. Thats becoming more and more likely I believe.

6103 data reviewed under NDA and then the big offers come.

Not here, obviously. But for Avacta...

Still all expecting big news here this week? Price action not exactly encouraging

We dont know what is coming or when though do we?

We just all are sat waiting in hope.

Daz, thought you worked in the industry? If thats true surely you know about the multiple M&A transactions made for small loss making biotechs with zero revenue?

Avacta sold there revenues generating diagnostics division because they dont need it. They'll never make any revenue ever but will be sold for multiple billions next year. Why? Perhaps you can tell us since you work in the industry, or claim to....

Let's compare to being 90% down here, diluted to oblivion and fighting a rising wave of warrants and 23% gain looks rather attractive id say.

Also, are you sure ive been in avacta 5 years? 🤔 like I said to JHFH whatever you weirdos think about me I'll agree with just be sure won't you hun. For your own protection of being made to look a tit whenever I feel like correcting you 😅

Erm, my average at avacta is around 52p mate. How's your imaginary short doing today? Remember to add more won't you pal. Can't loose 👍